Trial intelligence / Profile preview

Effect of Long-term PDE-5 Inhibition on Glucose Homeostasis Sub-study

NCT02129725Phase 4Completed

Sponsor
Vanderbilt University Medical Center
Start
Apr 2014
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sildenafil in metabolic syndrome, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), sponsored by Vanderbilt University Medical Center. Started Apr 2014; status: completed.

02

Drugs

sildenafil
03

Conditions

metabolic syndromeimpaired fasting glucose (IFG)impaired glucose tolerance (IGT)

Beyond the preview

Go deeper on NCT02129725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02129725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call